Homemarket Newsstocks News

Bajaj Healthcare begins trial run for new opium processing line in Gujarat

Bajaj Healthcare begins trial run for new opium processing line in Gujarat

Bajaj Healthcare begins trial run for new opium processing line in Gujarat
Read Time
2 Min(s) Read
Profile image

By CNBCTV18.com Nov 23, 2022 3:53:26 PM IST (Published)

Bajaj Healthcare was awarded contracts to manufacture Alkaloids and APIs, including processing 500 MT of unlaced poppy capsules along with straw and processing 100 MT of Opium Gum annually.

wealth-desk wealth-desk

Buy / Sell Bajaj Health share

Recommended Articles

View All

Bajaj Healthcare Ltd. on Wednesday announced the commencement of the trial run of a new production line for processing opium at Savli in the Vadodara district of Gujarat.


The new production line will produce Alkaloids and Active Pharmaceutical Ingredients (APIs) used in a wide range of pharmaceutical applications.

Bajaj Healthcare was the first private entity to be awarded tenders for the highly regulated opiate processing business by the Central government.

On July 12, the company was awarded two tenders from the government for manufacturing concentrated poppy straw (CPS), alkaloids, and active pharmaceutical ingredients (APIs) from unlanced poppy capsules along with straw through CPS and opium gum.

The Central government’s move came as a part of its initiatives to boost the yield of alkaloids used in various drugs.

Bajaj Healthcare was awarded contracts to manufacture Alkaloids and APIs, including processing 500 MT of unlaced poppy capsules along with straw and processing 100 MT of Opium Gum annually.

This new segment is expected to contribute Rs 25 to 30 crore by the financial year 2024. Commercial operations are expected to begin in the December quarter of the current financial year.

Shares of Bajaj Healthcare ended at Rs 404.15, up nearly 5 percent.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Most Read

Market Movers

View All
Top GainersTop Losers
CurrencyCommodities
CompanyPriceChng%Chng